Literature DB >> 27491786

Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Nina Wagenknecht1, Birte Becker1, Miriam Scheld1, Cordian Beyer1, Tim Clarner1, Tanja Hochstrasser2, Markus Kipp3.   

Abstract

There is a broad consensus that multiple sclerosis (MS) represents more than an inflammatory disease: it harbors several characteristic aspects of a classical neurodegenerative disorder, i.e., damage to axons, synapses, and nerve cell bodies. While several accepted paraclinical methods exist to monitor the inflammatory-driven aspects of the disease, techniques to monitor progression of early and late neurodegeneration are still in their infancy and have not been convincingly validated. It was speculated that the thalamus with its multiple reciprocal connections is sensitive to inflammatory processes occurring in different brain regions, thus acting as a "barometer" for diffuse brain parenchymal damage in MS. To what extent the thalamus is affected in commonly applied MS animal models is, however, not known. In this article we describe direct and indirect damage to the thalamus in two distinct MS animal models. In the cuprizone model, we observed primary oligodendrocyte stress which is followed by demyelination, microglia/astrocyte activation, and acute axonal damage. These degenerative cuprizone-induced lesions were found to be more severe in the lateral compared to the medial part of the thalamus. In MOG35-55-induced EAE, in contrast, most parts of the forebrain, including the thalamus were not directly involved in the autoimmune attack. However, important thalamic afferent fiber tracts, such as the spinothalamic tract were inflamed and demyelinated on the spinal cord level. Quantitative immunohistochemistry revealed that this spinal cord inflammatory-demyelination is associated with neuronal loss within the target region of the spinothalamic tract, namely the sensory ventral posterolateral nucleus of the thalamus. This study highlights the possibility of trans-neuronal degeneration as one mechanism of secondary neuronal damage in MS. Further studies are now warranted to investigate involved cell types and cellular mechanisms.

Entities:  

Keywords:  Axonal damage; Cuprizone; Demyelination; Gray matter; Microglia; Neurodegeneration; White matter

Mesh:

Substances:

Year:  2016        PMID: 27491786     DOI: 10.1007/s12031-016-0790-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  76 in total

Review 1.  The anatomy of sensory relay functions in the thalamus.

Authors:  E G Jones
Journal:  Prog Brain Res       Date:  1991       Impact factor: 2.453

2.  Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.

Authors:  Stefanie Kuerten; Traugott L Gruppe; Laura-Maria Laurentius; Christiane Kirch; Magdalena Tary-Lehmann; Paul V Lehmann; Klaus Addicks
Journal:  APMIS       Date:  2011-04-12       Impact factor: 3.205

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Authors:  C Bjartmar; G Kidd; S Mörk; R Rudick; B D Trapp
Journal:  Ann Neurol       Date:  2000-12       Impact factor: 10.422

Review 6.  Exploring the origins of grey matter damage in multiple sclerosis.

Authors:  Massimiliano Calabrese; Roberta Magliozzi; Olga Ciccarelli; Jeroen J G Geurts; Richard Reynolds; Roland Martin
Journal:  Nat Rev Neurosci       Date:  2015-03       Impact factor: 34.870

7.  Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis.

Authors:  Dae Yong Kim; Dooil Jeoung; Jai Youl Ro
Journal:  J Immunol       Date:  2010-05-28       Impact factor: 5.422

8.  Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.

Authors:  Athena M Soulika; Eunyoung Lee; Erica McCauley; Laird Miers; Peter Bannerman; David Pleasure
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

9.  Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: Implications for the pathophysiology of schizophrenia.

Authors:  Hong-Ju Yang; Haitao Wang; Yanbo Zhang; Lan Xiao; Richard W Clough; Ronald Browning; Xin-Min Li; Haiyun Xu
Journal:  Brain Res       Date:  2009-03-21       Impact factor: 3.252

10.  Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes.

Authors:  Johannes Goldberg; Moritz Daniel; Yasemin van Heuvel; Marion Victor; Cordian Beyer; Tim Clarner; Markus Kipp
Journal:  Cell Mol Neurobiol       Date:  2013-08-25       Impact factor: 5.046

View more
  13 in total

1.  What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?

Authors:  M M Schoonheim; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-27       Impact factor: 3.825

2.  Visualization of the Breakdown of the Axonal Transport Machinery: a Comparative Ultrastructural and Immunohistochemical Approach.

Authors:  Sebastian Rühling; Franziska Kramer; Selina Schmutz; Sandra Amor; Zhan Jiangshan; Christoph Schmitz; Markus Kipp; Tanja Hochstrasser
Journal:  Mol Neurobiol       Date:  2018-09-21       Impact factor: 5.590

3.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

4.  Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality.

Authors:  Ferdinand Schweser; Ana Luiza Raffaini Duarte Martins; Jesper Hagemeier; Fuchun Lin; Jannis Hanspach; Bianca Weinstock-Guttman; Simon Hametner; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  Neuroimage       Date:  2017-10-31       Impact factor: 6.556

5.  Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI.

Authors:  Ambica Mehndiratta; Constantina A Treaba; Valeria Barletta; Elena Herranz; Russell Ouellette; Jacob A Sloane; Eric C Klawiter; Revere P Kinkel; Caterina Mainero
Journal:  Mult Scler       Date:  2020-06-25       Impact factor: 6.312

6.  The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Authors:  Laura Salinas Tejedor; Tanja Wostradowski; Stefan Gingele; Thomas Skripuletz; Viktoria Gudi; Martin Stangel
Journal:  J Mol Neurosci       Date:  2017-01-26       Impact factor: 3.444

7.  Cuprizone-Containing Pellets Are Less Potent to Induce Consistent Demyelination in the Corpus Callosum of C57BL/6 Mice.

Authors:  Tanja Hochstrasser; Gianna Lisa Exner; Stella Nyamoya; Christoph Schmitz; Markus Kipp
Journal:  J Mol Neurosci       Date:  2017-02-25       Impact factor: 3.444

8.  Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.

Authors:  Michaela Andelova; Karolina Vodehnalova; Jan Krasensky; Eliska Hardubejova; Tereza Hrnciarova; Barbora Srpova; Tomas Uher; Ingrid Menkyova; Dominika Stastna; Lucie Friedova; Jiri Motyl; Jana Lizrova Preiningerova; Eva Kubala Havrdova; Bénédicte Maréchal; Mário João Fartaria; Tobias Kober; Dana Horakova; Manuela Vaneckova
Journal:  BMC Neurol       Date:  2022-07-19       Impact factor: 2.903

9.  Inflammatory demyelination alters subcortical visual circuits.

Authors:  Sheila Espírito Santo Araújo; Henrique Rocha Mendonça; Natalie A Wheeler; Paula Campello-Costa; Kimberle M Jacobs; Flávia C A Gomes; Michael A Fox; Babette Fuss
Journal:  J Neuroinflammation       Date:  2017-08-18       Impact factor: 8.322

10.  Thalamic Atrophy Plays a Crucial Role in the Effect of Asymptomatic Carotid Stenosis on Cognitive Impairment.

Authors:  Wen Zhang; Zhao Qing; Yongwei Hu; Mingran Shao; Jiaming Lu; Junxia Wang; Ming Li; Xin Zhang; Zuzana Nedelska; Jakub Hort; Zhishun Wang; Tong Qiao; Bing Zhang
Journal:  Clin Interv Aging       Date:  2020-11-06       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.